Oncology One Pty Ltd is a drug discovery company headquartered in Melbourne, Australia. We are developing targeted small molecule therapies for cancer patient populations with no currently effective treatments. Our strategy centres on building a diversified pipeline of highly differentiated small molecule drug candidates. We have a purpose-built business model that provides access to novel target biology, disease models and drug discovery infrastructure – while driving a return on investment and managing risk.
Oncology One has one clinical-stage program that is out-licensed to Pfizer Inc. and four drug discovery projects in partnership with Australian research organisations.